ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ClearPoint Neuro's total debt was $50.84M at Sep 30, 2026. For fiscal 2025 it was $49.08M. The highest annual figure on record is $49.08M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.08M | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $4.02M | +4.3% |
| FY2013 | Dec 31, 2013 | $3.85M | +92.6% |
| FY2012 | Dec 31, 2012 | $2.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $50.84M | +74.1% |
| Q2 FY2026 | Jun 30, 2026 | $50.23M | +74.1% |
| Q1 FY2026 | Mar 31, 2026 | $49.64M | – |
| Q4 FY2025 | Dec 31, 2025 | $49.08M | +5870.3% |
| Q3 FY2025 | Sep 30, 2025 | $29.20M | +4772.7% |
| Q2 FY2025 | Jun 30, 2025 | $28.85M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $822.02K | – |
| Q2 FY2020 | Jun 30, 2020 | $599.32K | – |
See a number that looks wrong?